Company intelligence / Profile preview

ReAlta Life Sciences

Norfolk, Virginia, United Statesrealtalifesciences.com ↗

Ownership: Private
Employees: ~20
Development stage: Phase 2

Overview

ReAlta's lead candidate RLS-0071 (pegtarazimod) has demonstrated an excellent safety profile and confirmed target engagement in First-in-Human Phase 1 clinical trials. The company is currently conducting Phase 2 clinical trials for RLS-0071 in newborns with hypoxic ischemic encephalopathy (HIE) and hospitalized patients with acute exacerbations of chronic obstructive pulmonary disease (COPD). RLS-0071 has received Orphan Drug Designation and Fast Track Designation from the FDA for HIE and acute graft-versus-host disease (aGVHD) treatment.[4][5][7]

Therapeutic areas: HematologyPulmonologyNeurologyImmunology
Modalities: Engineered peptides
Industry: Biotech

Drug pipeline

3 assets

pegtarazimod

2 more assets in the full pipeline.

Request access →

Partnerships

Children's Hospital of The King's DaughtersEriko Life Science VenturesEastern Virginia Medical School

Beyond the preview

Go deeper on ReAlta Life Sciences.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ReAlta Life Sciences.

Explore the full profile